US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC) — Denver, Colorado

US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC) is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC) has participated in 1 clinical trials.

Therapeutic areas: Advanced Solid Tumors, EGFR Positive Non-small Cell Lung Cancer, Colorectal Carcinoma.

Sponsors: Sumitomo Pharma America, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC)?

US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC) conducted?

US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC) has 1 clinical trials on record. Their work covers Advanced Solid Tumors, EGFR Positive Non-small Cell Lung Cancer, Colorectal Carcinoma.

Is US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC) accredited by Crixeo Health?

US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.